Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial

DOI Full Paper Access

41

Citations

22

References

2020

Year

Toby M. Maher, Maureen D. Mayes, Michael Kreuter, Elizabeth R. Volkmann, Martin Aringer, I. Castellví, Maurizio Cutolo, Christian Stock, Nils Schoof, Margarida Alves,

Arthritis & Rheumatology

Abstract

These results suggest that nintedanib has a clinically relevant benefit on the progression of SSc-ILD.

References

	Year	Citations

Page 1